Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2-Reference-Cited by-同舟云学术

Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2

Published:2021-03-22 Issue:6 Volume:6 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Yu Krystle K.Q.,Fischinger Stephanie^ORCID,Smith Malisa T.,Atyeo Caroline^ORCID,Cizmeci Deniz^ORCID,Wolf Caitlin R.,Layton Erik D.,Logue Jennifer K.^ORCID,Aguilar Melissa S.,Shuey Kiel^ORCID,Loos Carolin^ORCID,Yu Jingyou^ORCID,Franko Nicholas,Choi Robert Y.,Wald Anna^ORCID,Barouch Dan H.,Koelle David M.^ORCID,Lauffenburger Douglas^ORCID,Chu Helen Y.,Alter Galit^ORCID,Seshadri Chetan^ORCID

Funder

National Institutes of Health

Bill and Melinda Gates Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/146242/files/pdf

Reference74 articles.

1. Virological. Novel 2019 Coronavirus Genome. https://virological.org/t/novel-2019-coronavirus-genome/319 Accessed February 19, 2021

2. Johns Hopkins University of Medicine. Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html Accessed February 19, 2021

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

4. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

5. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study;Petrilli;BMJ,2020

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147;Cell Communication and Signaling;2024-07-04

2. Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children;The Journal of Infectious Diseases;2024-06-05

3. Diabetes and Infectious Diseases with a Focus on Melioidosis;Current Microbiology;2024-06-04

4. Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients;Clinical Proteomics;2024-02-22

5. Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210);Cytotherapy;2024-01